Results

Total Results: 9,462 records

Showing results for "cancer".
Users also searched for: colon cancer screening

  1. www.uspreventiveservicestaskforce.org/home/getfilebytoken/_9KLmyQyMnoE3agQJsgNE-
    November 01, 2011 - Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial … neoplasia 3: a retrospective cohort study. … Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical … intraepithelial neoplasia: a randomised con- trolled trial. … Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_disposition-comments.pdf
    February 13, 2012 - In addition, the prior probability of malignancy based on the patients risk of breast cancer is rarely … Anderson Cancer Center13 that compared length of survival of metastatic breast cancer patients treated … There is a considerable body of literature discussing lobular cancers and difficulties in detecting … biopsies revealed 34% malignancies, of which 78.4% were invasive cancers and 21.6% were ductal carcinoma … as distinguished from CADe (computer-aided detection), and CADq (computer-aided quantification of tumor
  3. www.uspreventiveservicestaskforce.org/home/getfilebytoken/TmzUNhP6dAtun5nLBKqrRv
    Screening for Skin Cancer Screening for Depression in Adults: Clinical Summary Population Adults
  4. www.uspreventiveservicestaskforce.org/home/getfilebytoken/cLuJZx55Z6ApzYv836rkSp
    Screening for Skin Cancer ASPIRIN FOR THE PREVENTION OF CARDIOVASCULAR DISEASE CLINICAL SUMMARY
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/2fycG-t73pJzd9fZgtc-mg
    Screening for Skin Cancer Screening for Chronic Obstructive Pulmonary Disease using Spirometry
  6. psnet.ahrq.gov/issue/unintended-exposure-patient-lisa-norris-during-radiotherapy-treatment-beatson-oncology-centre
    March 06, 2005 - Safety Innovations Ambulatory Safety Nets to Reduce Missed and Delayed Diagnoses of Cancer … September 26, 2012 Errors in the MRI evaluation of musculoskeletal tumors and tumorlike … August 9, 2011 Missed breast cancers at US-guided core needle biopsy: how to reduce them … April 21, 2011 Hidden danger, obvious opportunity: error and risk in the management of cancer
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-equity-protocol.pdf
    January 01, 2020 - incidence, advanced breast cancer, breast cancer mortality, and all-cause mortality, quality-of-life … Breast cancer screening 4. Cervical cancer screening 5. Colorectal cancer screening 6. … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity … / or exp colorectal neoplasms/ or exp lung neoplasms/ or uterine cervical neoplasms/ 25 exp Obesity
  8. www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening-2012
    March 15, 2012 - cervix and who do not have a history of a high-grade precancerous lesion (cervical intraepithelial neoplasia … Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical … intraepithelial neoplasia: a randomised controlled trial. … Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and … Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer
  9. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2012_MaskedStats_Core_Weighted.PDF
    January 01, 2012 - 14: Cancer of colon 92,285 0.25% 15: Cancer of rectum and anus 39,160 0.11% 16: Cancer of liver and … ; other and unspecified primary 7,400 0.02% 42: Secondary malignancies 200,480 0.55% 43: Malignantneoplasm without specification of site 8,775 0.02% 44: Neoplasms of unspecified nature or uncertain … behavior 45,235 0.12% 45: Maintenance chemotherapy; radiotherapy 163,390 0.45% 46: Benign neoplasm … of uterus 120,335 0.33% 47: Other and unspecified benign neoplasm 133,485 0.37% 48: Thyroid disorders
  10. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2015Q1Q3_Dx_Pr_Grps.PDF
    October 31, 2017 - W MCC 17,056 0.13% 181: RESPIRATORY NEOPLASMS W CC 15,163 0.12% 182: RESPIRATORY NEOPLASMS W/O CC/ … PROCEDURES FOR NEOPLASM W/O CC/MCC 9,617 0.07% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC … ; other and unspecified primary 2,557 0.02% 42: Secondary malignancies 77,663 0.60% 43: Malignant neoplasm … 16,642 0.13% 45: Maintenance chemotherapy; radiotherapy 55,034 0.43% 46: Benign neoplasm of uterus … 44,846 0.35% 47: Other and unspecified benign neoplasm 49,179 0.38% 48: Thyroid disorders 10,763 0.08%
  11. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2007_MaskedStats_Core_Weighted.PDF
    January 01, 2007 - non-epithelial cancer of skin 7189 0.02 24: Cancer of breast 95113 0.24 25: Cancer of uterus 41277 … 0.01 31: Cancer of other male genital organs 971 0.00 32: Cancer of bladder 38064 0.10 33: Cancer … ; other and unspecified primary 8458 0.02 42: Secondary malignancies 263493 0.67 43: Malignant neoplasm … 0.13 45: Maintenance chemotherapy; radiotherapy 184550 0.47 46: Benign neoplasm of uterus 210358 0.53 … 47: Other and unspecified benign neoplasm 165472 0.42 48: Thyroid disorders 46283 0.12 49: Diabetes
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
    January 01, 2011 - advantage plans and Part D prescription drug expenditures).4 Lung, colorectal, prostate, and breast cancers … Please refer to a companion Data Points brief for a detailed presentation of data on the types of cancers … or off-label use in cancer. … American Cancer Society Cancer Action Network. Cancer and Medicare: a chartbook. February 2009. … Novel agents on the horizon for cancer therapy. CA Cancer J Clin 2009;59:111-137. 11.
  13. www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening-2009
    February 15, 2009 - Features associated with increased risk for malignancy include: asymmetry, border irregularity, color … melanoma; in theory, early detection and treatment could reduce morbidity and disfigurement from these cancers … In addition to detecting false-positive lesions, screening identifies nonmelanoma skin cancers and thin … National Cancer Institute. Skin Cancer Screening (PDQ). National Cancer Institute, 2005. … American Cancer Society. Cancer Facts and Figures 2004 .
  14. hcup-us.ahrq.gov/reports/natstats/commdx/table1j.htm
    February 11, 2011 - Cancer of bladder [32] 10,019 18.79 0.03 … Cancer of pancreas [17] 2,706 5.14 0.01 … Secondary malignancies [42] 1,311 2.60 0.00 … Secondary malignancies [42] 10,713 21.70 0.03 … Other and unspecified benign neoplasm [47] 11,443 23.96 0.03
  15. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2008_MaskedStats_Core_Weighted.PDF
    January 01, 2008 - 14: Cancer of colon 108,893 0.27% 15: Cancer of rectum and anus 46,148 0.12% 16: Cancer of liver … ; other and unspecified primary 8,477 0.02% 42: Secondary malignancies 244,962 0.61% 43: Malignantneoplasm without specification of site 6,879 0.02% 44: Neoplasms of unspecified nature or uncertain … behavior 53,573 0.13% 45: Maintenance chemotherapy; radiotherapy 182,190 0.46% 46: Benign neoplasm … of uterus 189,585 0.48% 47: Other and unspecified benign neoplasm 170,261 0.43% 48: Thyroid disorders
  16. www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/webinars/cahps-cancer-care-transcript.pdf
    June 01, 2017 - Introducing the CAHPS Cancer Care Survey" Transcript Introducing the CAHPS® Cancer Care Survey … Cancer care represents a condition-specific survey for all realms of cancer care treatment. … cancer center. … ICD-10 CM diagnosis of a malignant neoplasm. … And what about hematologic malignancy patients? Kathleen Yost Right.
  17. www.uspreventiveservicestaskforce.org/uspstf/recommendation/skin-cancer-screening-2001
    April 01, 2001 - , or squamous cell skin cancer. … ("A," "B," "C," "D"), or rapidly changing lesions are features associated with an increased risk of malignancy … from melanoma, but early detection and treatment may reduce morbidity and disfigurement from these cancers … No studies were found that evaluated whether screening improves the outcomes of these cancers. … Prevention of skin cancer.
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-2008
    October 15, 2008 - Although single test performance is an important issue in the detection of colorectal neoplasia, the … Unfortunately, data that permit assessment and comparison of screening methods to detect colorectal neoplasia … The lead time between the detection and treatment of colorectal neoplasia and a mortality benefit is … insufficient evidence to assess the sensitivity and specificity of fecal DNA testing for colorectal neoplasia … Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/QTkyWhfQHqFUy4He2B6HU4
    KQ2: Detection of advanced cancers (e.g., stage IIA/IIB) and stage distribution of any invasive breast … Interval cancers (false negative and incident cancers presenting clinically between screening visits … Studies are needed that report outcomes such as the rates of advanced breast cancers diagnosed across … and across multiple rounds of followup, including interval cancers. … cancer at the time of screening and across multiple rounds of followup, including interval cancers
  20. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49434/psn-pdf
    February 01, 2004 - Optimizing outcomes from cervical neoplasia involves multiple steps: the patient's ability and willingness … Cervical neoplasia is a slow growing disease, taking 10-30 years to progress from Human Papilloma Virus … (HPV) infection and low grade neoplasia to invasive cancer. … virus or more sensitive screening tests such as the Thin-Prep smear to detect clinically important neoplasia … Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou